Manufacturer record
Megasys Biotek Pvt. Ltd: regulatory record
Last checked 3 November 2026. Source: CDSCO monthly NSQ alerts and state drug-testing laboratories
1 batch manufactured by Megasys Biotek Pvt. Ltd (Kerala) was declared Not of Standard Quality in February 2026. Records are batch-specific findings by government laboratories as published in CDSCO's monthly alerts; where a company has stated that a flagged batch was counterfeit, that statement is noted when reported.
Most recent flagged batch: GF12503, Glimepiride Tablets IP, 1mg (exp Jun 2027). DTL Konni (state lab) found it not of standard quality: Sample fails the test Dissolution mentioned in the Laboratory Protocol as per IP. Listed in the February 2026 alert.
Records by type
1 record linked to Megasys Biotek Pvt. Ltd in the datasets we hold. A zero means nothing is on record in those datasets, not that nothing ever happened. What the labels mean.
CDSCO drug alerts: Not of Standard Quality and spurious drugs
Scope. A company appearing here is not a finding that its products are unsafe. Regulatory actions can apply to one batch, one formulation, one period or one state. Always check the linked government document for the current position, and tell us if something is out of date. How we label records.
Flagged batches per year
All flagged batches
| Product | Batch | Reason declared NSQ | Tested by | Alert |
|---|---|---|---|---|
| Glimepiride Tablets IP, 1mg | Batch GF12503Mfg Jul 2025 · Exp Jun 2027 | Sample fails the test Dissolution mentioned in the Laboratory Protocol as per IP.Dissolution | DTL KonniState lab | Feb 2026 |
Right of reply. Manufacturers may submit a response or a laboratory re-test result; it is published unedited alongside this record. Submit a response.